Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11912987 Methods for screening for cancer targets

Patent 11912987 was granted and assigned to KSQ Therapeutics on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 2 Mar, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 2 Mar, 2024
Edits made to:
Infobox (+33 properties)
Article (+58 characters)
‌

 US Patent 11912987 Methods for screening for cancer targets

Article

Patent abstract

This invention describes a novel CRISPR/Cas

Infobox
Is a
Patent
Patent
0
Patent Applicant
KSQ Therapeutics
KSQ Therapeutics
0
Current Assignee
KSQ Therapeutics
KSQ Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119129870
Patent Inventor Names
Micah Benson0
Date of Patent
February 27, 2024
0
Patent Application Number
173569880
Date Filed
June 24, 2021
0
Patent Citations
‌
US Patent 11078481 Methods for screening for cancer targets
0
‌
US Patent 8546553 Prokaryotic RNAi-like system and methods of use
0
‌
US Patent 8697359 CRISPR-Cas systems and methods for altering expression of gene products
0
‌
US Patent 8771945 CRISPR-Cas systems and methods for altering expression of gene products
0
‌
US Patent 8795965 CRISPR-Cas component systems, methods and compositions for sequence manipulation
0
‌
US Patent 8865406 Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
0
‌
US Patent 8871445 CRISPR-Cas component systems, methods and compositions for sequence manipulation
0
‌
US Patent 8889356 CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
0
‌
US Patent 8889418 Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
0
‌
US Patent 8895308 Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
0
‌
US Patent 8906616 Engineering of systems, methods and optimized guide compositions for sequence manipulation
0
‌
US Patent 8906682 Methods for treatment of cancer
0
‌
US Patent 8932814 CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
0
‌
US Patent 8945839 CRISPR-Cas systems and methods for altering expression of gene products
0
‌
US Patent 8993233 Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains
0
‌
US Patent 8999641 Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains
0
‌
US Patent 9637739 RNA-directed DNA cleavage by the Cas9-crRNA complex
0
‌
US Patent 9790490 CRISPR enzymes and systems
0
‌
US Patent 9822372 CRISPR-Cas component systems, methods and compositions for sequence manipulation
0
‌
US Patent 9834791 CRISPR-related methods and compositions with governing gRNAS
0
‌
US Patent 9840713 CRISPR-Cas component systems, methods and compositions for sequence manipulation
0
‌
US Patent 9855297 Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system
0
‌
US Patent 9890393 Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system
0
Patent Primary Examiner
‌
Christian C Boesen
0

Find more entities like US Patent 11912987 Methods for screening for cancer targets

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.